The estimated Net Worth of Leo Lee is at least $7.41 Million dollars as of 31 October 2022. Mr. Lee owns over 45,000 units of Insmed Inc stock worth over $7,149,761 and over the last 6 years he sold INSM stock worth over $0. In addition, he makes $257,500 as Independent Director at Insmed Inc.
Leo has made over 1 trades of the Insmed Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 45,000 units of INSM stock worth $796,050 on 31 October 2022.
The largest trade he's ever made was buying 45,000 units of Insmed Inc stock on 31 October 2022 worth over $796,050. On average, Leo trades about 5,625 units every 0 days since 2018. As of 31 October 2022 he still owns at least 98,265 units of Insmed Inc stock.
You can see the complete history of Mr. Lee stock trades at the bottom of the page.
Leo Lee serves as Independent Director of the Company. Mr. Lee is a Chief Executive Officer and Executive Director of Regeneus Ltd. (ASX: RGS) since 2017. Mr.Lee has more than 21 years of experience in the pharmaceutical industry in Japan; most recently at Merck KGaA, a global pharmaceutical company, where he served as President, Japan. Prior to his role at Merk KGaA, Mr. Lee served as President, Japan of Allergan plc, a global pharmaceutical company, from 2011 to 2015. Before that he served as Vice President of Sales at Merck & Co. from 2008 to 2011. From 2003 to 2008, he held various commercial positions at IQVIA (Cegedim Dendrite), a life sciences services company. Mr. Lee also served in various roles at Accelrys, Inc., a software company serving pharmaceutical and biotech companies, from 1997 to 2003. Currently, Mr. Lee serves on the Board of Directors of Regeneus Ltd, a global pharmaceutical company based in Australia. Mr. Lee received a B.S. in Molecular Genetics and Microbiology from the University of California, Los Angeles. Mr. Lee has more than 21 years of experience in the pharmaceutical industry in Japan. The Board believes that Mr. Lee's experience in commercial leadership roles in Japan and the Asia Pacific region brings value to the Board as the Company seeks to expand in this geography.
As the Independent Director of Insmed Inc, the total compensation of Leo Lee at Insmed Inc is $257,500. There are 16 executives at Insmed Inc getting paid more, with William Lewis having the highest compensation of $7,175,090.
Leo Lee is 50, he's been the Independent Director of Insmed Inc since 2018. There are 20 older and 3 younger executives at Insmed Inc. The oldest executive at Insmed Inc is Steinar Engelsen, 70, who is the Independent Director.
Leo's mailing address filed with the SEC is 700 US HIGHWAY 202/206, , BRIDGEWATER, NJ, 08807.
Over the last 21 years, insiders at Insmed Inc have traded over $46,121,705 worth of Insmed Inc stock and bought 1,080,212 units worth $8,226,993 . The most active insiders traders include Llc Fmr, William Lewis, and Dennis M Lanfear. On average, Insmed Inc executives and independent directors trade stock every 38 days with the average trade being worth of $2,452,158. The most recent stock trade was executed by Orlov S Nicole Schaeffer on 10 September 2024, trading 37,575 units of INSM stock currently worth $407,689.
insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.
Insmed Inc executives and other stock owners filed with the SEC include: